Med Gen Announces Release of FABULUST(R)
8:00a ET October 15, 2007 (Business Wire)
Med Gen Inc. (OTCBB:MGEN) ("MGEN"), manufacturers of nationally branded OTC healthier life products and specialty financial services reports that after 1.5 years of Research and Development, its newest product FABULUST(R) is ready for market. The FABULUST(R) product website can be viewed at www.fabulust.net and is linked to the company website www.medgen.com.
FABULUST(R) is an intimate female stimulant aimed at the 46% of women or an estimated 50 million women that reportedly fail to reach satisfaction with their bed partners. The problem and its solution have been the topic of many medical studies emphasizing the importance that sex plays in our daily lives. Finally, Med Gen has introduced a uniquely different product that can be universally accepted, easy to use, enjoy and inexpensive. It is the first roll-on application for a market that exceeds $1.2 billion.
FABULUST(R) ads will appear shortly in OutlawBiker and Tabu magazines as ticklers, while TV commercials and airtime are procured. The company intends to enter this market with sophisticated TV spots similar to Cialis(R) and Viagra(R).
Along with FABULUST(R), the company is now finishing two new commercials for its Painenz(R) and Snorenz(R) products. These commercials will air in late October and run through 2008.
In a recent Analyst communication, Mr. Kravitz, Chairman and CEO talked about the raising of substantial capital and the near term emphasis of the company, much of which will be devoted to the marketing of its unique product lines. In this way, he concludes, the company can develop a strong revenue stream and increase shareholder value.
